-
Je něco špatně v tomto záznamu ?
Risk factors for superficial vein thrombosis in patients with primary chronic venous disease
D. Musil, M. Kaletova, J. Herman,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, pozorovací studie
- MeSH
- chronická nemoc MeSH
- dospělí MeSH
- genetická predispozice k nemoci MeSH
- hodnocení rizik MeSH
- index tělesné hmotnosti MeSH
- kouření škodlivé účinky epidemiologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- logistické modely MeSH
- odds ratio MeSH
- prevalence MeSH
- retrospektivní studie MeSH
- rizikové faktory MeSH
- rodokmen MeSH
- rozdělení chí kvadrát MeSH
- sexuální faktory MeSH
- věkové faktory MeSH
- žilní insuficience diagnóza epidemiologie MeSH
- žilní trombóza diagnóza epidemiologie genetika MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- pozorovací studie MeSH
- Geografické názvy
- Česká republika MeSH
BACKGROUND: Primary chronic venous disease (CVD) is associated with an increased risk of superficial vein thrombosis (SVT). While CVD is a predominant factor in SVT, there is a range of additional predisposing factors. The objective was to investigate the association between age, gender, BMI, smoking, oestrogen hormone therapy, family history of venous thromboembolism (VTE) and CEAP clinical classification in patients with CVD and a history of SVT. PATIENTS AND METHODS: In a retrospective observational study on consecutive patients with primary CVD, 641 outpatients were enrolled (152 men, 23.7%; 489 women, 76.3%). The prevalence of SVT was evaluated according to age, BMI, smoking, presence of family history of VTE, use of hormone therapy, and clinical class of CVD. RESULTS: Risk of SVT was significantly increased in women (OR 1.68, 95% CI = 1.02-2.76; p = 0.041), older patients (46-69 years, OR 1.57, 95% CI = 1.03-2.4; p = 0.036, ≥ 70 years, OR 2.93, 95% CI = 1.5-5.76; p = 0.001), smokers (OR 1.69, 95% CI = 1.1-2.58; p = 0.015) and in persons with first-degree siblings diagnosed with VTE (OR 2,28, 95% CI = 1.28-4.05; p = 0.004). The risk was significantly increased in older male smokers (p - 0.042). In women, smoking and oestrogen therapy (p = 0.495) did not increase the risk of SVT even older women or in those with increased BMI. In CVD (C0-C3), a history of episodes of SVT was found in 103/550 (18.7%), in chronic venous insufficiency (CVI) in 27/91 (29.7%). There was a significantly higher prevalence of SVT in patients with CVI (OR 1.70, 95% CI = 1.1-2.5; p = 0.016). CONCLUSIONS: In patients with primary CVD, SVT was significantly associated with female gender. In men, older age, smoking and positive family history of VTE were relevant SVT risk factors. In women, risk factors were older age, BMI ≥ 25 kg/m2 and positive family history of VTE. Compared with C0-C3 clinical classes, CVI significantly increases the risk of SVT.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16019992
- 003
- CZ-PrNML
- 005
- 20160801114831.0
- 007
- ta
- 008
- 160722s2016 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1024/0301-1526/a000497 $2 doi
- 024 7_
- $a 10.1024/0301-1526/a000497 $2 doi
- 035 __
- $a (PubMed)26986712
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Musil, Dalibor $u 1 Department of Internal Medicine I, Cardiology, Teaching Hospital, Olomouc, Czech Republic.
- 245 10
- $a Risk factors for superficial vein thrombosis in patients with primary chronic venous disease / $c D. Musil, M. Kaletova, J. Herman,
- 520 9_
- $a BACKGROUND: Primary chronic venous disease (CVD) is associated with an increased risk of superficial vein thrombosis (SVT). While CVD is a predominant factor in SVT, there is a range of additional predisposing factors. The objective was to investigate the association between age, gender, BMI, smoking, oestrogen hormone therapy, family history of venous thromboembolism (VTE) and CEAP clinical classification in patients with CVD and a history of SVT. PATIENTS AND METHODS: In a retrospective observational study on consecutive patients with primary CVD, 641 outpatients were enrolled (152 men, 23.7%; 489 women, 76.3%). The prevalence of SVT was evaluated according to age, BMI, smoking, presence of family history of VTE, use of hormone therapy, and clinical class of CVD. RESULTS: Risk of SVT was significantly increased in women (OR 1.68, 95% CI = 1.02-2.76; p = 0.041), older patients (46-69 years, OR 1.57, 95% CI = 1.03-2.4; p = 0.036, ≥ 70 years, OR 2.93, 95% CI = 1.5-5.76; p = 0.001), smokers (OR 1.69, 95% CI = 1.1-2.58; p = 0.015) and in persons with first-degree siblings diagnosed with VTE (OR 2,28, 95% CI = 1.28-4.05; p = 0.004). The risk was significantly increased in older male smokers (p - 0.042). In women, smoking and oestrogen therapy (p = 0.495) did not increase the risk of SVT even older women or in those with increased BMI. In CVD (C0-C3), a history of episodes of SVT was found in 103/550 (18.7%), in chronic venous insufficiency (CVI) in 27/91 (29.7%). There was a significantly higher prevalence of SVT in patients with CVI (OR 1.70, 95% CI = 1.1-2.5; p = 0.016). CONCLUSIONS: In patients with primary CVD, SVT was significantly associated with female gender. In men, older age, smoking and positive family history of VTE were relevant SVT risk factors. In women, risk factors were older age, BMI ≥ 25 kg/m2 and positive family history of VTE. Compared with C0-C3 clinical classes, CVI significantly increases the risk of SVT.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a věkové faktory $7 D000367
- 650 _2
- $a index tělesné hmotnosti $7 D015992
- 650 _2
- $a rozdělení chí kvadrát $7 D016009
- 650 _2
- $a chronická nemoc $7 D002908
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a logistické modely $7 D016015
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a odds ratio $7 D016017
- 650 _2
- $a rodokmen $7 D010375
- 650 _2
- $a prevalence $7 D015995
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a hodnocení rizik $7 D018570
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a sexuální faktory $7 D012737
- 650 _2
- $a kouření $x škodlivé účinky $x epidemiologie $7 D012907
- 650 _2
- $a žilní insuficience $x diagnóza $x epidemiologie $7 D014689
- 650 _2
- $a žilní trombóza $x diagnóza $x epidemiologie $x genetika $7 D020246
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a pozorovací studie $7 D064888
- 700 1_
- $a Kaletova, Marketa $u 1 Department of Internal Medicine I, Cardiology, Teaching Hospital, Olomouc, Czech Republic.
- 700 1_
- $a Herman, Jiri $u 2 Department of Surgery II - Vascular and Transplantation Surgery, Teaching Hospital, Olomouc, Czech Republic.
- 773 0_
- $w MED00004632 $t VASA. Zeitschrift für Gefässkrankheiten $x 0301-1526 $g Roč. 45, č. 1 (2016), s. 63-6
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26986712 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160722 $b ABA008
- 991 __
- $a 20160801115059 $b ABA008
- 999 __
- $a ok $b bmc $g 1154662 $s 944520
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 45 $c 1 $d 63-6 $i 0301-1526 $m VASA $n VASA $x MED00004632
- LZP __
- $a Pubmed-20160722